A phase 2a trial administered the novel drug HT-6184 to its first patient with lower-risk myelodysplastic syndromes. The first patient in a phase 2a clinical trial has received a dose of HT-6184, a ...
A new national study shows for the first time that people exposed to Agent Orange face a higher risk of developing myelodysplastic syndrome (MDS), tend to develop it earlier, and often have more ...
In just the last 2 years there have been updates in classification, risk assessment, and response criteria in myelodysplastic syndromes (MDS), but additional efforts are needed to improve these, and ...
Myelodysplastic syndromes (MDS) are a group of blood cancers that affect the bone marrow and can result in a low levels of blood cells. When MDS affects red blood cells, it can lead to anemia in some ...
Outpatient care for MDS patients can improve mental health and quality of life, reducing caregiver strain and hospital stays. Celiac disease is associated with increased risks for various cancers, ...
People with MDS have fewer red and white blood cells and platelets. Blood transfusions may be needed if you have MDS and experience anemia or thrombocytopenia. Myelodysplastic syndromes (MDS) are a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback